These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11364440)

  • 1. DMP 266 study opens at Jefferson.
    Crit Path AIDS Proj; 1997; (No 32):30-1. PubMed ID: 11364440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMP 266 on the horizon.
    Vazquez E
    Posit Aware; 1997; 8(5):25. PubMed ID: 11364636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efavirenz (SUSTIVA, formerly DMP-266) 48-week data announced.
    AIDS Treat News; 1997 Sep; (No 279):2-3. PubMed ID: 11364690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No more twice-a-day Crixivan.
    Vazquez E
    Posit Aware; 1998; 9(6):17. PubMed ID: 11366469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efavirenz expanded access.
    Highleyman L
    BETA; 1998 Jan; ():4. PubMed ID: 11364975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustiva added to three-drug combination.
    AIDS Patient Care STDS; 1998 Oct; 12(10):803. PubMed ID: 11362030
    [No Abstract]   [Full Text] [Related]  

  • 7. Some competition for 1592.
    GMHC Treat Issues; 1997; 11(4/5):10-1. PubMed ID: 11364373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
    Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
    [No Abstract]   [Full Text] [Related]  

  • 9. What's new and what's next.
    Fakuda D
    Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DMP 266 and indinavir combination.
    AIDS Patient Care STDS; 1997 Aug; 11(4):287-8. PubMed ID: 11361845
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on antivirals.
    Proj Inf Perspect; 1997 Nov; (23):8-11. PubMed ID: 11365381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMP-266 and adefovir dipivoxil: 2 new AIDS drugs available to patients without treatment options.
    Baker R
    BETA; 1997 Sep; ():6-7. PubMed ID: 11364709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efavirenz shows promising results.
    AIDS Patient Care STDS; 1998 Jan; 12(1):64-5. PubMed ID: 11361892
    [No Abstract]   [Full Text] [Related]  

  • 14. Don't mix Sustiva with Fortovase.
    Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
    Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
    N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First once-daily drug simplifies dosing, offers new options in HIV-1 treatment.
    AIDS Alert; 1998 Nov; 13(11):121-4. PubMed ID: 11365967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRIA clinical trials.
    Newsline People AIDS Coalit N Y; 1998 Sep; ():59. PubMed ID: 11367496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DMP 266 now available.
    Gilden D
    GMHC Treat Issues; 1997 Sep; 11(9):5-6. PubMed ID: 11364751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update from the 5th Conference on Retroviruses and Opportunistic Infections.
    Vazquez E
    Posit Aware; 1998; 9(3):21-3. PubMed ID: 11365483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efavirenz (Sustiva) may equal or exceed protease inhibitor in initial antiretroviral combination.
    James JS
    AIDS Treat News; 1998 Jul; (No 299):1-3. PubMed ID: 11365599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.